3rd Quarter - Amendment
INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 10, 2012 | $10,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Aug 22, 2013 | $10,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
CMS Aerage Manufacturer Price (AMP) Final Rule, Reporting by manufacturers and calculation. Potential prescription drug track-and-trace legislation. RxTEC National Average Drug Aquisition Cost (NADAC) implementation. Calculation and process. National Average Retail Price (NARP) implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JIM DRISCOLL | — |
| MARK EUGENE KINNEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.